Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TRANSITION THERAPEUTICS INC. T.TTH

"Transition Therapeutics Inc is a product-focused biopharmaceutical company. The Company is engaged in developing therapeutics for disease indications with markets. Its technologies are focused on the treatment of Alzheimer's disease and diabetes."


TSX:TTH - Post by User

Post by deninsaskon Feb 25, 2008 11:55am
185 Views
Post# 14538269

Aricept fails to slow progression of AD

Aricept fails to slow progression of AD Researchers conclude Acetylcholinesterase inhibitor drugs are unable to slow progression from mild cognitive impairment (MCI) to dementia. https://www.alzforum.org/new/detail.asp?id=1699 Like we didn't know that..... These AChEIs are the current drugs with wide spread Rx use such as Aricept---Exelon---Reminyl---etc. https://www.cnsforum.com/imagebank/item/Drug_neostig/default.aspx These are drugs with only a Symptomatic Labelling and do not slow progression of the disease but just helps memory a bit for a short period of time with a suspect risk/reward abstract from a safety point of view. MCI a tough Indication to target but lots of studies and precedents for Transition & ELAN to sift through whilst researching for their AZD-103 Phasell in MCI or Pre-Alzheimers as Dr. Cruz calls it.
Bullboard Posts